MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview
  • Bile Acids: A Novel Multiple Sclerosis Therapy?
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

Facebook Live

Facebook Live: Special Guest Announcement

MStranslate
September 28, 2022
Dr Travis Stiles, Q&A, Research, Videos
On September 25, 2022, our co-founder and chief science communicator, Brett Drummond, took to Facebook Live with a very special guest, Dr Travis Stiles (CEO, Novoron Bioscience). Many who follow MStranslate...
Digoxin

Heart Medication Shows Potential to Repair Myelin

MStranslate
August 16, 2022
Remyelination, Research, Treatments
Research Summary: Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis The ability to repair myelin damage...
Epstein-Barr virus

How Could Epstein-Barr Virus Trigger MS?

MStranslate
July 21, 2022
Epstein-Barr virus, Research
1 Comment
In this third instalment of our video series on Epstein-Barr virus (EBV) and its potential role in multiple sclerosis (MS), our co-founder and chief science communicator, Brett Drummond, explores a Stanford...
Epstein-Barr virus

EBV T-Cell Treatment for MS: Trial Update

MStranslate
July 13, 2022
Epstein-Barr virus, Progressive MS, Research, Treatments
Research Update: ATA188 Phase 2 EMBOLD Study Today, Atara Biotherapeutics provided an update on their Phase 2 randomised clinical trial, called the EMBOLD study, which is testing the safety and effectiveness...
Epstein-Barr virus

Study Shows How EBV May Help Trigger MS

MStranslate
June 29, 2022
Epstein-Barr virus, Research
Research Summary: Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM New studies linking Epstein-Barr virus (EBV) to multiple sclerosis have been the biggest research news of...
biomarker

Understanding Science: What is a Biomarker?

MStranslate
June 8, 2022
Understanding Science
We often hear the term 'biomarker' used in medical research, but what does it mean? In the video below, our co-founder and chief science communicator, Brett Drummond, answers this very question. As part of...
Novoron Bioscience

Novoron Bioscience: Remyelination Research

MStranslate
May 16, 2022
Dr Travis Stiles, Remyelination, Research
In the past, our co-founder, Brett Drummond, and MStranslate partner, Dr Travis Stiles, have talked broadly about developments in remyelination research around the world.  However, they have never really...
Dr Barry Singer

ACTRIMS Forum 2022 Insights – Dr Barry Singer

MStranslate
April 4, 2022
ACTRIMS, Conferences, Research
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) held its annual meeting between February 24 and 26 in West Palm Beach, Florida.  Unfortunately, due to ongoing travel...
milk multiple sclerosis

Does Drinking Cow’s Milk Worsen MS Symptoms?

MStranslate
March 10, 2022
Diet, Research, Symptoms
A new study from the University of Bonn has investigated whether a protein found in cow's milk can lead to damage of the central nervous system. In the below research summary video, our co-founder, Brett...
Wahls Protocol

Study Compares Wahls & Swank Diets in MS

MStranslate
January 29, 2022
Diet, Research
Written by Brett Drummond (MStranslate co-founder), in collaboration with Joey Lambert (MStranslate intern) The impact of diet on the quality of life of a person living with multiple sclerosis (MS) is of...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Posts

  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkValues & Standards